Literature DB >> 4484602

Case studies on remediable health defects.

L B Callan, A McCray.   

Abstract

Mesh：

Year:  1972        PMID： 4484602     DOI： 10.1111/j.1746-1561.1972.tb00972.x

Source DB:  PubMed          Journal:  J Sch Health        ISSN： 0022-4391            Impact factor:   2.118


× No keyword cloud information.
  6 in total

1.  Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

Authors:  R Vatapalli; V Sagar; Y Rodriguez; J C Zhao; K Unno; S Pamarthy; B Lysy; J Anker; H Han; Y A Yoo; M Truica; Z R Chalmers; F Giles; J Yu; D Chakravarti; B Carneiro; S A Abdulkadir
Journal:  Nat Commun       Date:  2020-08-19       Impact factor: 14.919

2.  A genomic and epigenomic atlas of prostate cancer in Asian populations.

Authors:  Jing Li; Chuanliang Xu; Hyung Joo Lee; Shancheng Ren; Xiaoyuan Zi; Zhiming Zhang; Haifeng Wang; Yongwei Yu; Chenghua Yang; Xiaofeng Gao; Jianguo Hou; Linhui Wang; Bo Yang; Qing Yang; Huamao Ye; Tie Zhou; Xin Lu; Yan Wang; Min Qu; Qingsong Yang; Wenhui Zhang; Nakul M Shah; Erica C Pehrsson; Shuo Wang; Zengjun Wang; Jun Jiang; Yan Zhu; Rui Chen; Huan Chen; Feng Zhu; Bijun Lian; Xiaoyun Li; Yun Zhang; Chao Wang; Yue Wang; Guangan Xiao; Junfeng Jiang; Yue Yang; Chaozhao Liang; Jianquan Hou; Conghui Han; Ming Chen; Ning Jiang; Dahong Zhang; Song Wu; Jinjian Yang; Tao Wang; Yongliang Chen; Jiantong Cai; Wenzeng Yang; Jun Xu; Shaogang Wang; Xu Gao; Ting Wang; Yinghao Sun
Journal:  Nature       Date:  2020-03-25       Impact factor: 49.962

Review 3.  Resistance to second-generation androgen receptor antagonists in prostate cancer.

Authors:  Keith T Schmidt; Alwin D R Huitema; Cindy H Chau; William D Figg
Journal:  Nat Rev Urol       Date:  2021-03-19       Impact factor: 14.432

Review 4.  Understanding and overcoming resistance to PARP inhibitors in cancer therapy.

Authors:  Mariana Paes Dias; Sarah C Moser; Shridar Ganesan; Jos Jonkers
Journal:  Nat Rev Clin Oncol       Date:  2021-07-20       Impact factor: 66.675

5.  Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.

Authors:  Yongfeng He; Jiaqi Mi; Adam Olson; Joseph Aldahl; Erika Hooker; Eun-Jeong Yu; Vien Le; Dong-Hoon Lee; Won Kyung Kim; Diane M Robins; Joseph Geradts; Zijie Sun
Journal:  Oncogene       Date:  2020-02-24       Impact factor: 9.867

6.  Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.

Authors:  Benjamin S Simpson; Niedzica Camacho; Hayley J Luxton; Hayley Pye; Ron Finn; Susan Heavey; Jason Pitt; Caroline M Moore; Hayley C Whitaker
Journal:  Commun Biol       Date:  2020-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.